Sanofi, FDA and Dupixent
The FDA has determined that the monoclonal antibody pemivibart (Pemgarda) is likely to be effective against currently ...
In September 2024, the U.S. Food and Drug Administration (FDA) issued three guidance documents to support different clinical ...
For years, kratom has been clouded by controversy, largely fueled by media portrayals that paint a negative picture of this ...
Pet owners are advised to throw away the at-risk products safely, so pets and children can't access and ingest them ...
The treatment offers hope to thousands of patients who do not respond to existing medications, and has shown promise in treating other neurological disorders.
The U.S. Food and Drug Administration has approved a new drug for adults with schizophrenia,  the FDA announced Thursday.
The FDA has approved a first-in-class antipsychotic that targets cholinergic receptors without blocking dopamine receptors.
The pet food was found to be contaminated with bacteria that can cause illness and even death in pets and humans.